EyePoint Pharmaceuticals has agreed to pay the U.S. government $4,657,463.18 to resolve False Claims Act allegations tied to its ophthalmic drug DEXYCU. According to a July 17 news release by the ...
13h
Capital One releases VulnHunter, an open-source AI tool that finds software flaws before hackers do
Capital One has open-sourced VulnHunter, an AI security tool that finds exploitable code flaws, maps attack paths and helps ...
Custom prompts, specialized bots and even AI employees — the portfolio manager is vibe coding a new way of working ...
University of Virginia postdoctoral researcher Róża Przanowska investigates how long non-coding RNA structural domains drive ...
Morning Overview on MSN
An mRNA pancreatic-cancer vaccine kept most responders alive six years later, follow-up data show
Half of the patients who received an experimental mRNA vaccine for pancreatic cancer after surgery remained free of disease ...
Spread the love“`html Discord has transformed the way communities connect, offering a platform where gamers, hobbyists, and ...
Zacks Investment Research on MSN
Here's why you should retain INSP stock in your portfolio for now
Inspire Medical Systems INSP is well-positioned for solid growth over the next few quarters as it navigates a significant ...
Spread the love“`html In a surprising turn of events, cybersecurity researchers have recently uncovered a significant vulnerability affecting major AI model hosting platforms. This exploit, driven by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results